ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000996.1|Frontalamides_1 # 37 # 6117 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000996.1|Frontalamides_1 	37	6117	-	Loose	500	28.4906	CTX-M-241	36.36	3005664	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GTGCAGGTAGTGCGCTTCGAGACCCAGTTCCTCGATCATCCCGGTCGCCCAGGGGCCCCAGTCGAGCGCGAGCGCGGGCAGTCCGGCCGCGCGGCGGCGGTGCGCGAGGGCGTCGAGGAAGGCGTTGCCCGCCGCGTAGTTGGTCTGCCCCGCGGTCGTGAGGAGCGAGGCGACGGAGGCGAAGAGGACGAAGTGCTCCAGCGGTTCGTCCCGCAGGTGCTTGTCGAGCAGGTGGGCCCCGGCGGTCTTCGGGGCGTGGACGGTGTCGAAGGCTTCGCGGTCGATGTCGGCGAGGAGCGTGTCGCGGACCTGCCCGGCAAGGTGGAAGACGCCGCGCAGCGGGGGCGGGTCGCCCGCGCGGTACGTGGCGAGCCAGCCCGTGAAGGCGGCCTCGTCGGTGAGGTCGACGGGGGCGAGCACGACGCTCGCGCCGAGCGCTTCGATGTCCCTGACCAGCGCGATCGCCCGCCCGGCCCGGCTGTCGGGGTCGGTCGCGCGCCACGCGGCGCGCGGCGGCAGCGGGGTCCGGCCGAGGAGGACGAGGCGCCGCGCGCCGCGCCGTACGAGGGTGCGGCACAAGAGCCGGCCGAGCGCGCCGAAGGCCCCGGTCACGAGGTACGTGCCGTCCGGGCGCAGGCGGGGCGGGAGCGGTCCGGTGAGGCGGTCCTCGGCGGGCCTGAGCCGCAGCGTGGCGCGCGTGGCGCCGCGCAGGCCGATCTCCTCCTCGTCGTCGGCGAGGAATTCGGCGAGCAGCGTCGCCGCCTCGTCGGACGCGGTGGCCCGCGCGGGGTCGAGGTCGACGAGCTTGCCCCGGTGTCCCGCGAGTTCCTGGTGGCGCAGGACGCGCGTGACGCCCCAGGCGGGTGCCCCGAGCGGTTCCACGGCGTCTTCGGCGGCGACGGGCTGGGCCCCGCGCGTCACGACGTGCAGGCGGCACGTGTCGCGGCGGGCGCGCAGCACGCGGGCGAGGGCGACGAGCGTCCACGCGCCGCGCGCGGTCGCCACCCCCACCTGCGCGGCCGGGACACCGGCCAGCGCGGGGTGCCCGAGGTTCCACAGGTGGACGACCTCGCCGCGGAACGGCGCTCCCTCGCCGTCGAGTTCGGCGAAGAGCCGGTCGAGGTGCACCGGATCCTCGGGGGCGAGCGTCACGTCCCCGGCCTCGTCCCGCGCGTACCGCGTCCCGGCCCGTACGAGGCGGCAGCGGTCGCCCCGTTCCCGTACGAGCGCGGCGAAGGCGTCGGCGACGCCGGTGGTGTCGGCGAGCACGAGCCAGTCGCGCGGGGCCTCGGCACCGGGTTCCGGCGTCGCGTCGAGTGCCGGGACCGGCACCCATTCCGGCACCGCGAGCCACGAGTCCACGGTCGCCCGGGACACGGTCGTGGAGACCTGGTCGATGTCGGCGGCGCGGAAGCCGGTCACGCGTCCGAGCGCGGTGCCGTCCTCGGCGTCGTACAGCGCGAGGTCGGCGAGGAGTTCCCGGCCGTCGTCCCGCGTCACCGTGCCGTGCACCCACAGCGCCCGGTCGCCGCTCGCGGCGAGGTCGAGTTCGCCGAGCGAGAGCGGGAGCCGTACCCCGGAGGCGGGGGCCGACTCCGGGCCGTCGGGAATCTGCCGCGTGAGGAGCGCCTGGAAGCAGGCGTCGAGCAGCACGGGGTGCAGGTGGTGGTCGGCCGCGTCCGGGCCGAGGAGCCCGGCGGGCGGGCGTACCTTCGCGAGCACTTCGCCCTCGCCCGTCCACACCTCCTCGATGGCCTGGAAGGCGGGCCCGTAGTGGTAGCCGAGCGCCGCGAGCCCCGCGTAGCACGTCTCCGCGTCGAGCCGGCGGTCCGCGCGGGCCCGGACCCCGGCCACGTCGAGCACGGGCCCCAGCGAAGCGGGCTGCCCGGAGCGCAGGACCCCGGCCGCGTGCACGACGGGCTCGGTGTCCGCGTCCCCCGGGGTCGCGATCGTGAACGCGGCCGTCTCGGGGTCGACGCTGAGCTGGACGGTGCTCGTGGCGTCCTCGGCGAGGAAGAGCGCCTTGCGCAGGTCGATCCCGGCGAGGCGCACGCGCGTCGCGCCCGTCAGGGCCCGTACGGCCTGCGCGGCCATCTCGACGTACCCGGCGGCCGGGAAGACGGCCGTGCCCTGGATCTGGTGGTCGGCGAGGTACGGGAGCCGCTCGGTGTCGAGCGCGGACTCCCACGTGGGCGCGGCGTGCGTGCTGCGGCGGCCGAGGAGCGGGTGGTCGAGGTGCCCGAGGCGTACGCGGGCGACGTTCGCGGGCTCGACCCAGTGCCGCTCCTCGCGCCACGGGTACGCGGGCAGCGGGACCGTCGTCCCGGTGGGCTGGAGGGTGTCCCAGTCGATGGCGCGGCCGAGCGTGTGCAGGGTCGCGAGCGAGACGGCGAAGCGTTCCGGCTCGTCCTCGGCGCGGCGGATCGAGGGCACGGTGACGGCCTCGTGCCCGGTGGCCTCGGCGCACTCGCGCAGGGAGTGGGCGAGCGCGGGGTGCGGGCCGATCTCCAGGAAGAGCCGGTGCCCGTCGCGGGCGAGCCGGTCGACGGCGGAGCGGAAGTGGACGCGTTCGCGCACGTTGCGCCACCAGTAGGCGGCGTCGAGGCGCACCCCGTCCGCGTTCGACTCCATCCCGGTGAGTTCCAGGGGGACCTGGGGCGGCTGCGGGTCGAGGAAGGCGAGCGAGTCGAGGAGTTCGTCCTTGATCGCGTCCATCTTGTGCGAGTGGTAGGGGACTTCGACGGTCAGCGCCTTGGCGAAGATCTGCTCCCCGGTGAGCCGCGCGGCCAGTTCCTCCAGCGCGTCGGTGTCGCCCGCGAGGGTCACCGCGCCGGGGCTGTTCACGGCCGCGACGGCCACGCGCCCCCGGTACGCGCGCAGTTCGCGCTCCGCCTCCTCCTCGGGGAGCCCGACCGCGAGCATCCCGCCGGTCCCGGCGAGCTTGTGCTGGAGGCGGCTGCGGTGCACGGCGATCGCGCACGCCTCGCGCAGCGTGTAGACCCCGGCCTCGTGGAAGGCGGCGATCTCGCCCGTGCTGTGCCCGACGATCGCCTCGGGCCGCACCCCGTACGAGCGCCAGAGCCGCGAAAGGCCGTACTGGACCGCGAAGTTGGCGGGCTGCGCGAGCCACGTCTCCGCCATCCGCGAGGACTCGGCGTCTCTGCCCATCTCCTCCAGGAGCGACCAGCCCGCGAGGTCGTGGATCTCCCGGTCGCACTCCTCGACGGCCGCCCGGAAGACGGGTTCGCTCGCGAGGAGCCCCTGTCCCATGCCCCACCACTGCGGGCCCATCCCGGTGTACACCCACACGAGCCGCCGGTCCTCGGGCTCCAGGCGCCGGTTCTCGACGACGCGCGGGTGCGGGTTCCCCGCGGCGTAGGCGTCGAGGGCCTCGCGCAGCGACTCGCGGGACGAGTGGACGACCGCGAGCCGCGTCTCCAGGTGCTGCCTGCGGTGCGCGAGGGTGTGCCCGAGGTCGGCGAGCGCCACGTCCCCGTCCAGCTCGTCCCGCACCTGCGCCGCCTTGCGCGCGAGTGCCTCGGGGTGCCGGGTGCTGAGCGGCAGCACGGTCCAGGGGCGGGCGAGGGCGGCGGGCCCGGCGCCGGACCGTGCCGGGGCCTCCTCGATGATCAGGTGCGCGTTCGTCCCGCCGAAGCCGAAGGAGTTCACGCCCGCCCGCGCCGGTCCCTCGTGCGCGGGCCACGGTGTGGCGACGGCGGGGATCTCGTAGGGGAGGCTGTCGGCGTCGATCGCGGGGTTGAGCGTGTCGAGGTGCAGGTGGGGCGGGATGACCTTGTGCTCGACGGCGAGCGCGGTCTTGATGAGCCCGGCGATCCCGGCGGCCGACTCGGTGTGCCCGATGTTGGTCTTGACGGAGCCGACGTAGCAGGCGGCGCCGGGCGCGCGGCCCTCGGCGAGCACGCGCGCCAGCGCGTTCGCCTCGATCGGGTCGCCGACGGGCGTCGACGTGCCGTGCGCCTCGACGTACTGGAGCTGTCCGGGCGAGATCCCGGCGTCCGCGCACACCTCCCGCACGAGGCGGGTCTGCGCCTCGCCGCTCGGTACGGTGATGCCGGGGGTGCGGCCGTCCTGGTTGACGCCGCTGCCCGTGAGCACGGCGTGGATCGGGTCGCCGTCGCGCAGCGCGTCCGAGAGCCGCTTGAGCGCGACGAGCCCGACGCCCTCGGCCCGTACGTACCCCTCGGCGCTTGCGTCGAAGGCGCGCGAACTCCCGCTGCGCGAGAGGAAACCGCCCTTCGTCTCGGCGATCGTGTACTGCGGCGTCATGTGCAGCAGCACACCGCCCGCGAGGGCGAGATCGGTCTCGCCGCGCAGGAGCGCCTGGCGGGCGAGGTGCACGGTGACGAGCGAGGAGCTGCACGCCGTGTCGACGGTGAGGCTCGGGCCGCGGAAGTCGAAGACGTGCGAGATGCGGTTCGAGACCATCGTCATCATCGTGCCCGTCGCGGTGTGCGCGGCGAGCGTCTCGAAGCCGAGGTCGGCGAACTGGAGGATCTTGTAGTCGAGCGTGAACGCCCCGACGTAGACGGCCGTGTTGGAGCCGACGAGGGTCTGCGGGCGCTGCCCGCCGTCCTCCAGCGCCTCCCAGGCGACCTCCAGGAGCTTGCGCTGCTGCGGGTCCATGTGGTCGGCCTCGCGCCCGCTGATCCCGAAGAAGGCGGGCTCGAAGCGGTCGAAGCCGTCGATGTAGCCGCCGCGTCCGCCGGTGAGGCGGCCCGGCTTGTCGCGGTGGCGGCTGCCGAGCGTCGTGGTGTCGTAGCGGTCGGCGGGCGTGGGTGTCACGCAGTCCTTGCCGGTGACCAGGTTCCGCCAGTAGGCACGGTGGTCGCCCGCGCCGCCGGGGAGCCGGCAGCCGATCCCGATGATCGCGACCTTCTCGCCCTCCGCGACCGGTGCGCGCGGGGACGGGGGCGGGGCGGGCGGGTCCTGGGCGGTGGCGTGGTGGTGCGCGGGCTGCGGGGCGTCAGCGCGCGGGGCTCCCGTGGCCGGGGACTCGCTGTGGGCGGCGGCCATGTGGGCACACTCCTCGGGTTCGCGCGTCCTCCGGGAGCGGTCCGGGGCGCGGCAAAGTCTGCTGGTGGTACGGGTGAAGGGCGGTGGGGAGTCGGGACGTCGGTACGGGGACGGGACCGGGCGGGACGCGGGTCTCGCTCAGGCGCCCTGGCGGCCGTCCGTGGGGGCGACGGGGGCCTCCTCCTCCCGCGGGCGTGGGGAGCGCCGTACGGGGTGGAGGAGGCTGCCGAGGACGTCGCCGGTCCGCGGGAAGGAGGCGGGGTCGTGGAGCCCCACGGCGGCGGGCGTGCGGCCCGGGTGCCAGGTGAAGCTGCCGAAGAGGTGGTCCCACACGGAGAGGTCGGAGCCGTAGTGCCCGGCCTCGGCGAGCCGCGTGCTGTGGTGCAGGCGGTGCTGCTCGGGGCTGGCCAGGACGTGGTTGAACGGGCCGATCCGGACGTCGATGTTGGCGTGGATGAAGTAGCCCTGCGCCGCGACGAAGAGCCCGGAGGCGAGCACGGAGTGGGCGGAGAACCCGACGGCGGCGAGCAGGAGTTGCACGCAGCCCTGGGAGAAGACGATGTCGAGCACGTGGTTGACGCCGTTGTTCGCCACGTTGACCTTCGCCGGGACGTGGTGCACGCCGTGGAGCTTCCACAGGTGCTTGTTGGTGTGGCCGAGCCGGTGGGTGACGTAGCCGGCAAGGGAGCCGGCGAGGAGCGTGAGGGGCAGTTCGGCCCAGAGCGGCAGCACCGGGTGGCCCGTCGCGACGAGCGTCATGAGGCCCGTGACGAGGAACTGCGCGAAGGCGCTCGCGAGCATCGTGAGCACGAACCAGATGCCGTACCAGCGCCACTCCGCGGCGGTCGGCTGCCAGTCGCGCTCGTAGGGGACGAGCCGCTCCAACGCCGTCAGGTACAGCACGACGCCCATGAGGAAGAACGGGCTCACCCGCTCCGGGTCCCAGTCCCGCGCGAGGGCGAGGCCCGCGACGAGCACGGTGGCGACGAGCAGCACCGGATAGGCGAGGAAACGCAGCAGCGCCCTGCCGTGCCCGGCCACGACTGA	MQVVRFETQFLDHPGRPGAPVERERGQSGRAAAVREGVEEGVARRVVGLPRGREERGDGGEEDEVLQRFVPQVLVEQVGPGGLRGVDGVEGFAVDVGEERVADLPGKVEDAAQRGRVARAVRGEPAREGGLVGEVDGGEHDARAERFDVPDQRDRPPGPAVGVGRAPRGARRQRGPAEEDEAPRAAPYEGAAQEPAERAEGPGHEVRAVRAQAGRERSGEAVLGGPEPQRGARGAAQADLLLVVGEEFGEQRRRLVGRGGPRGVEVDELAPVSREFLVAQDARDAPGGCPERFHGVFGGDGLGPARHDVQAARVAAGAQHAGEGDERPRAARGRHPHLRGRDTGQRGVPEVPQVDDLAAERRSLAVEFGEEPVEVHRILGGERHVPGLVPRVPRPGPYEAAAVAPFPYERGEGVGDAGGVGEHEPVARGLGTGFRRRVECRDRHPFRHREPRVHGRPGHGRGDLVDVGGAEAGHASERGAVLGVVQREVGEEFPAVVPRHRAVHPQRPVAARGEVEFAEREREPYPGGGGRLRAVGNLPREERLEAGVEQHGVQVVVGRVRAEEPGGRAYLREHFALARPHLLDGLEGGPVVVAERREPRVARLRVEPAVRAGPDPGHVEHGPQRSGLPGAQDPGRVHDGLGVRVPRGRDRERGRLGVDAELDGARGVLGEEERLAQVDPGEAHARRARQGPYGLRGHLDVPGGREDGRALDLVVGEVREPLGVERGLPRGRGVRAAAAEERVVEVPEAYAGDVRGLDPVPLLAPRVRGQRDRRPGGLEGVPVDGAAERVQGRERDGEAFRLVLGAADRGHGDGLVPGGLGALAQGVGERGVRADLQEEPVPVAGEPVDGGAEVDAFAHVAPPVGGVEAHPVRVRLHPGEFQGDLGRLRVEEGERVEEFVLDRVHLVRVVGDFDGQRLGEDLLPGEPRGQFLQRVGVAREGHRAGAVHGRDGHAPPVRAQFALRLLLGEPDREHPAGPGELVLEAAAVHGDRARLAQRVDPGLVEGGDLARAVPDDRLGPHPVRAPEPRKAVLDREVGGLREPRLRHPRGLGVSAHLLQERPAREVVDLPVALLDGRPEDGFAREEPLSHAPPLRAHPGVHPHEPPVLGLQAPVLDDARVRVPRGVGVEGLAQRLAGRVDDREPRLQVLPAVREGVPEVGERHVPVQLVPHLRRLARECLGVPGAERQHGPGAGEGGGPGAGPCRGLLDDQVRVRPAEAEGVHARPRRSLVRGPRCGDGGDLVGEAVGVDRGVERVEVQVGRDDLVLDGERGLDEPGDPGGRLGVPDVGLDGADVAGGAGRAALGEHARQRVRLDRVADGRRRAVRLDVLELSGRDPGVRAHLPHEAGLRLAARYGDAGGAAVLVDAAAREHGVDRVAVAQRVREPLERDEPDALGPYVPLGACVEGARTPAAREETALRLGDRVLRRHVQQHTAREGEIGLAAQERLAGEVHGDERGAARRVDGEARAAEVEDVRDAVRDHRHHRARRGVRGERLEAEVGELEDLVVERERPDVDGRVGADEGLRALPAVLQRLPGDLQELALLRVHVVGLAPADPEEGGLEAVEAVDVAAASAGEAARLVAVAAAERRGVVAVGGRGCHAVLAGDQVPPVGTVVARAAGEPAADPDDRDLLALRDRCARGRGRGGRVLGGGVVVRGLRGVSARGSRGRGLAVGGGHVGTLLGFARPPGAVRGAAKSAGGTGEGRWGVGTSVRGRDRAGRGSRSGALAAVRGGDGGLLLPRAWGAPYGVEEAAEDVAGPREGGGVVEPHGGGRAARVPGEAAEEVVPHGEVGAVVPGLGEPRAVVQAVLLGAGQDVVERADPDVDVGVDEVALRRDEEPGGEHGVGGEPDGGEQELHAALGEDDVEHVVDAVVRHVDLRRDVVHAVELPQVLVGVAEPVGDVAGKGAGEEREGQFGPERQHRVARRDERHEARDEELREGAREHREHEPDAVPAPLRGGRLPVALVGDEPLQRRQVQHDAHEEERAHPLRVPVPREGEARDEHGGDEQHRIGEETQQRPAVPGHD	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	701.04	gnl|BL_ORD_ID|3501|hsp_num:0	4570			441	540	
BGC0000996.1|Frontalamides_2 # 6460 # 9504 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.736	BGC0000996.1|Frontalamides_2 	6460	9504	-	Loose	650	26.9498	MexH	61.11	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGCGGTGAGCGGCAGCGCGCCGACCTCGGTGAGGTGCGCGGGGACGAGGTACGAGGGCAGCGCGTCCGCGAGCGCGCGGCGCAGCGCGGCGCGGCTCACCTCGGCACCCGGCTCGGCCACGTACCAGGCGCACAGCGCGTCCTCGCCGCCCGCCCCCGGGCGGACCGCGACGACGGCGCGCGCGATGCCGTGCCGCGCGGCGAGGTGGGCCTCGATCTCGCCCGTCTCGATGCGGTGCCCGCGCAGCTTGACCTGACTGTCGGCGCGGCCGAGGAGGTGGAGCCGCCCGGCGGTGTCCCACCGGGCCAGGTCGCCCGTGCGGTAGAGCCGTTCGGCGGGGGTGTCCGGGAGCAGCGCGCGCTCCGTGAACCGTTCGGCGGTCAGCTCGGGCCGGCCCGCGTACCCGAGCGCGACCCCCTCGCCGCCGATCCACAGCTCCCCGGTGATCCCGGCGGGCAGCGGGTTGCCGTGCGGGTCCAGGACGTGGAGCGTGGCGTGCGGGAGCGGGCGGCCGACGGGGACGGCGAGCCCGGGGTCGAGCCCGTCGGCCGGGCCCTCGAAGAAGGCGCTGTCGATCGTGGCCTCGGTGACGCCGTACGAGTTCAGGACGCGCGTGCCGGGTCCCGCCAGCTCCCTCAGCCGCTCGTACTCGGCGACCTTCCACGTGTCGGAGCCGACGACGAGGAGCCGCAGGAAGCCGAGCCCGGCGCCTTCGCGGGCGCAGTGGTCCATGAGGCCGCGCACGAGGGCGGGCACGAACTCGGCGCAGTCCACGCGCTCCTCGCGCAGGACCTCGTACAGACGCGCGGTGTCGAGCAGCAGGTCGCGCCCGGCGAGGACGAGCGTCCCGCCCGAGCACAGGGCGCGCACGAGGTCGCCCGTGAAGACGTCGAACGACGGCTGCGCGCTCTGGAGATGGACGCGCACCTCGTCGCCGAGGCGGTACTCGCGGTGCCAGGAGGCGTAGGCGGCGGCGAGGTTGCGGTGGGCGACGCGGACGGCCTTCGGTTCGCCGGTGGAACCGGAGGTGTGGATGACGTAGGCGGGCGCGTCGAGGTCGTCGGCGGGCTCGCCGCCCCTGTGCGGTTCGGCGGCGGCCAGTTCGGTGACCGAGAGCTGTCGGCAGGGGGAGCCTTCCGGGGTCGGCACCCCGTCCGCCGTGATCACCAGCGAGGCCCCCGCGCCCGCGAGCACCTTCGCGAGGCGTTCGGCGGGGAGCGCCGGGTCGAGCGGCAGGTAGGCGCCCCCGGCCCGCAGTACCGCGAGGAGGTGGGCCACCAGCTCGGGCGACTTGGGCAGCGCGACCCCGACGACGGAGCCGCGGCCGATGCCGAGGGAGCGCAGCCGCGAGGCCAAGCCCGCCGACGAAGCAGCGAGTTCCCCGTATGTCACGGAGGCTCCGCCGGGCACCCGTACCGCGACCGCCGAGGCGTTCTCGCGCGCCGCCCGCTCGAAGAGCCGGTGCACCGGGACGGCGTCCGCGGCGAGCGCCCGGCGCCCGGCCCCGCTCGTCTCCCGTACCAGTTCCTCGCGTTCGTGCGCGGCGAGCATGTCGAGCGCCGAGACGGGCTCGTCGGGCGCCGCGTGGGTGAGGCTGTCGAGCAGTCGCGTGTAGTGCGCGGCCATGCGGCGCACGGTCGCGGGGTCGAAGAGGTCGGTGTTGTACTTCAGGACGCAGTGGAAGCGCCCCTCCGACTCCTCCTCGTACACGCTCAGTGTCAGGTCGAACTGGCCTTCTTCCTCGGGCAGTTCGATGTACTCCAGGCGGTAGCCGTACTGCTCCGTGGCGACCTTGTGCGTGAGCAGGATGAACATCGCCTGGAAGACGGCGGAGCGGCTGGAGTCGTGCTGGAGGCCGAGTTCGTCGACGAGGAGCACGAAGGGGTACTCCTGGTGGTCGAGCCCGCCGAGCACCGTGTCGCGCACCTGCGTGAGCAGCGCCTCGACGCCCGGGTCCCCGGAGAGGTCCGCGTGCAGCGGCAGCGGGTTGACGAAGTACCCGTACACGGAGGAGAACTCCTGCCGCGTGCGGCCCGTCACGGGACTGCCCACGACGAGGTCGTCCTGCCCGGACCAGCGGTGCAGGAGCACGTAGTACGTGGCGAGGAGCACCATGAACGGGGTGACGCCGTGCCGCTGCGCGAGCGTGTGCACGCGGGCGCTGAGGGCCTCGTCGAGCACGAAGAACTCCGAGGCGCCGTTGTGCGTCTGCACGGCCGGGCGGGGGCGGTCGGTGGGCAGGTCCAGGAGCGGGACCTCGGCGGGGAGGTGGTCGCGCCAGTAGTCGCGCATGCGCGCGGCCTCGGGCGAGGCGAGGAACCTGTTCTGCTGGTTGAGGAAGTCGACGTACCGGGCCGGGACGGGCGCGAGCGCCGGTTCGCGGCCCTCCTTCAGGGCCTCGTAGACCTCCAGCAGTTCCTCGATGAAGGTGAACGTCGACACCGCGTCCGAGACGATGTGGTGGACGGCCTTCATGATGACCCAGCGGTCGGGGCCGCGCCGGAAGAGCCGGAAGCGGAAGAGCGCGTCGTGCTCCAGGTCGTACCGCGCGCGGTACTCGTGGATGATCCGCTCCTTGATCTCCTCCCACTCCTGGCCCTCGACGTCGAACCAGCCGAGGTCGGGCTCGCGGCCGTCGCCGATGCGCTGCACGGGGCGGCCCTCGCGCAGATGGAAGCCGGTGCGCAGCGCGGGGTGGCGGGCGACGAGCCGGCGGACGGCCGCGAACATCAGCTCGGGGTCGAGCACGGCCCGCACCTCGACGGCGCCGCCGATGTTGTAGGCGTGCCCGTCGGGGTTGAGCTGCTTGAGGAACCAGAGCGCCTTCTGGTTCTGGGTGAGCGGGAAGTCCCCGTCGTCGTCCCAGAGTTCGACGGTGACCTGGGCGCCGGAAAGCTCGTCCCGCGCGAGGCGTTCGGTCAGCTCCTCGTGCAGGCGCGTGGCCAGCTCGGCGACGGGGGTGTTGCTGAGCAGCGCGACGACGGGCGGCGCGACGCCCAGTTCGGCCTGCGAGCGGGCCCGCAGCTCCATCGCGAGGAGTGA	MRGERQRADLGEVRGDEVRGQRVRERAAQRGAAHLGTRLGHVPGAQRVLAARPRADRDDGARDAVPRGEVGLDLARLDAVPAQLDLTVGAAEEVEPPGGVPPGQVARAVEPFGGGVREQRALREPFGGQLGPARVPERDPLAADPQLPGDPGGQRVAVRVQDVERGVRERAADGDGEPGVEPVGRALEEGAVDRGLGDAVRVQDARAGSRQLPQPLVLGDLPRVGADDEEPQEAEPGAFAGAVVHEAAHEGGHELGAVHALLAQDLVQTRGVEQQVAPGEDERPARAQGAHEVAREDVERRLRALEMDAHLVAEAVLAVPGGVGGGEVAVGDADGLRFAGGTGGVDDVGGRVEVVGGLAAPVRFGGGQFGDRELSAGGAFRGRHPVRRDHQRGPRAREHLREAFGGERRVERQVGAPGPQYREEVGHQLGRLGQRDPDDGAAADAEGAQPRGQARRRSSEFPVCHGGSAGHPYRDRRGVLARRPLEEPVHRDGVRGERPAPGPARLPYQFLAFVRGEHVERRDGLVGRRVGEAVEQSRVVRGHAAHGRGVEEVGVVLQDAVEAPLRLLLVHAQCQVELAFFLGQFDVLQAVAVLLRGDLVREQDEHRLEDGGAAGVVLEAEFVDEEHEGVLLVVEPAEHRVAHLREQRLDARVPGEVRVQRQRVDEVPVHGGELLPRAARHGTAHDEVVLPGPAVQEHVVRGEEHHERGDAVPLRERVHAGAEGLVEHEELRGAVVRLHGRAGAVGGQVQERDLGGEVVAPVVAHARGLGRGEEPVLLVEEVDVPGRDGRERRFAALLQGLVDLQQFLDEGERRHRVRDDVVDGLHDDPAVGAAPEEPEAEERVVLQVVPRAVLVDDPLLDLLPLLALDVEPAEVGLAAVADALHGAALAQMEAGAQRGVAGDEPADGREHQLGVEHGPHLDGAADVVGVPVGVELLEEPERLLVLGEREVPVVVPEFDGDLGAGKLVPREAFGQLLVQARGQLGDGGVAEQRDDGRRDAQFGLRAGPQLHREE	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	274.05	gnl|BL_ORD_ID|1350|hsp_num:0	1344			480	534	acriflavine; tetracycline; norfloxacin
BGC0000996.1|Frontalamides_3 # 10357 # 10503 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.782	BGC0000996.1|Frontalamides_3 	10357	10503	+	Loose	500	21.1718	OXA-85	33.33	3001780	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCCCGGCTCCTGGCACGGGTCCTCGGCGGCCGGGCACCGCGCCCTGTGCGGCTTCGGGACGCACGCCGAGATGCTCGACGCGGAGCACCTGCCGCGCAACGCGGAGCTGGTGCGGCGCCTGCTCGACGGGGAGGCGGGGGCGTGA	MPGSWHGSSAAGHRALCGFGTHAEMLDAEHLPRNAELVRRLLDGEAGA	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	18.90	gnl|BL_ORD_ID|260|hsp_num:0	289			669	732	cloxacillin; oxacillin; cefalotin
BGC0000996.1|Frontalamides_4 # 10500 # 12350 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000996.1|Frontalamides_4 	10500	12350	+	Loose	600	30.0314	Streptomyces venezuelae rox	45.45	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGAGCGCGGCCGAGACGGCGGCGGAGGCGGCGGTGCGGGCGGAGGAGGCCGTGCGGTCGGAGAGGGCGGAGGGGTCGGAGGCGTCCGTGCGCTCGGAGACGGCCGCGCGCTCGGAGGCGGCCGTGGGGGAGGGGGTGGCCGGGGTTCCGGCCGCCCGGCCCGGCGCCGCCGCGCAGGCGCCCGCCACCGACTGGGAGTCCCGCGAGCCCACCCCGGGGACCCCGCCCCGCGTCCTCGTGATCGGGGCCGGGCTCGCGGGGCTCGCGGCGGGCTCGTACGGGCGGATGAGCGGGCTGCGGACGCTCGTCCTGGAGAAGCACGTGCTCCCCGGCGGCTGCTGCACCGCGTGGTCGCGCGAGGGGTACGTCTTCGACTACTGCATCGAGTGGCTCATCGGCACCGCCGAGGGCAACGAGGCGCACCAGGTGTGGCGCGAACTCGGGGCGCTCGACGGGAAGTCGGTGACGAACTTCGAACTGTTCAACAAGGTCGTCGGCAGGGACGGCCGCGAGGTCGTCTTCTGGAACGACCCGGACCGGCTCGAAGCGCACCTCCTGGAGCTGTCCCCGGCGGACGCCCCGCACATCCGGGCGTACTGCCGTGACCTGCGGCGCTTCCAGAAGATCGAGCTGTACCCCTTCCTCACCGCGCCCGCGCTGAAGACGCTCGGCGAGAAGCTGCGCACCCTGCGCACCGTCCTGCCCGCCTTCCGGCTCTTCTGGCGCAACGCCGCGACGCCGATGCACGCCTTCGCCGACAAGTTCCAGGACCCCCTGCTGCGGACCGCCTTCCGCAACATCTTCTTCCAGGACCCCGAGGGCTTCCCCGTCCTGCCGTACCTCTTCAACATGGCGAGCGCCTACCACGGCAACGCGGGCTTCCCGCAGGGCGGTTCGCTCGGGCTCGCCCGCTCGGTCGAGGAGCGGTACACGGGGCTCGGCGGGGAGATCCGCTACCGGGCCCGCGTGGAACGCGTCCTCGTCGAGGACGACCGCGCGATCGGCGTCGTACTGCGCGGCGGGAAGACGCTCTACGCCGAGCACGTCATCTCCGCCGCCGACGGCGACACCACGATCAAGGGCCTGCTCGGCGGCCGGTACACGGGCCCCAGGATCGACAAGCTGTACGAGGAGCTGCTCGACCAGGAGGGGACGTTGTTCCCCGCCGTCGTCTCGGCCTTCGTCGGCATCGAGGGCGGCCTCCCCGAGGGCGACGCGCACAGCACGACGTACCTCCTCGACGAGCAGGACGCGGCGCGCCTCCCCGGCGGCCTCCAGTCCAGCATCGTCGTGCAGCTCCGCTCCCGCTACGCGGACGGCTTCGCGCCCGAGGGCAAGTCCGTCGTGCACTGCACGTACTTCAGCGACTACGGGTACTGGGCGGACCTCCGCGCGAAGGACCGCCGCGCCTACCGGGCCCGCAAGAGCGAAGTCGCGGCTTTCGTGCGGGAGTTCCTGGAGCGGAAGTGGCCCGAGGTGGCCGGGCGCATCGAGCTGGTCGACGTCGCCTCGCCCGCGACGACGCGCCGCTACACCGGCAACCACAAGGGCTCGATCCTCGCCTGGAAGGCGTTCTCGGAGGCCGACGACATCTCCGCGAAGCTCGTCGGCAAGGACCGTATGCGCCTGCCGGGGCTCGCCGGATTCTCGATGGCGGGCCAGTGGGTCGGCATGGGCGGGCTCATCCGCGCCGCGTCGACCGGGCGCTTCGCCGTCCAGTACCTGTGCGACGAACTCGGGCTTCCCTTCCGGGCGTTCGAGAGCGAGAACACCGAGCCCTGGCACCCCGGAAAGCTCGGCAGCCTTCCCCAACTGGACCGCTGGAACGAACGCGAGGAGCGGGGCCGATGA	MSAAETAAEAAVRAEEAVRSERAEGSEASVRSETAARSEAAVGEGVAGVPAARPGAAAQAPATDWESREPTPGTPPRVLVIGAGLAGLAAGSYGRMSGLRTLVLEKHVLPGGCCTAWSREGYVFDYCIEWLIGTAEGNEAHQVWRELGALDGKSVTNFELFNKVVGRDGREVVFWNDPDRLEAHLLELSPADAPHIRAYCRDLRRFQKIELYPFLTAPALKTLGEKLRTLRTVLPAFRLFWRNAATPMHAFADKFQDPLLRTAFRNIFFQDPEGFPVLPYLFNMASAYHGNAGFPQGGSLGLARSVEERYTGLGGEIRYRARVERVLVEDDRAIGVVLRGGKTLYAEHVISAADGDTTIKGLLGGRYTGPRIDKLYEELLDQEGTLFPAVVSAFVGIEGGLPEGDAHSTTYLLDEQDAARLPGGLQSSIVVQLRSRYADGFAPEGKSVVHCTYFSDYGYWADLRAKDRRAYRARKSEVAAFVREFLERKWPEVAGRIELVDVASPATTRRYTGNHKGSILAWKAFSEADDISAKLVGKDRMRLPGLAGFSMAGQWVGMGGLIRAASTGRFAVQYLCDELGLPFRAFESENTEPWHPGKLGSLPQLDRWNEREERGR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	129.41	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	108	rifampin; rifaximin; rifapentine
BGC0000996.1|Frontalamides_5 # 12347 # 12445 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.707	BGC0000996.1|Frontalamides_5 	12347	12445	+	Loose	1000	20.0162	MCR-3.21	42.11	3007262	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGACGACCGCGCACGAGGAGGGGCGGGCCGATGACGACCGCGCACGAGAAAGGGCGGGCCCGATGACGACCGCGTACGAAGAAGGGCGGGCCCGATGA	MTTAHEEGRADDDRARERAGPMTTAYEEGRAR	MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNFVFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPIIVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDDRARNSEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTIRYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYKFAPDDQTRVPMQVWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNVQ	5.91	gnl|BL_ORD_ID|4882|hsp_num:0	5867			879	936	colistin A; colistin B
BGC0000996.1|Frontalamides_6 # 12442 # 14256 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.707	BGC0000996.1|Frontalamides_6 	12442	14256	+	Loose	550	31.5722	Nocardia farcinica rox	35.14	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACGAGCCGCTCCACCGCCCCCCCGGCCCAGCTCGCCGAGGAGGAGCGCCAAAGCGCGCGGGCCGGGAAGCGCCGCGAGACCGTGCTGATCATCGGGGCGGGCCTCGGCGGGCTCTCCACCGGCGTCTACGCGCAGCTGAACGGCTACCGGTCCCGCGTCCTGGAGATGCACGAGATCCCCGGTGGCTGCTGCACCGCCTGGGAGCGCGGGGACTACACCCTCGACGCCTGCGTGAGCTGGCTGCTCGGCAGCGGCCCCGGCAACGAGATGCACCAGATCTGGCTCGAACTCGGCGCCCTCCAGGGCAAGGAGGTCCGCCACTTCGACGTGTTCAACGTCGTCCGCGACACCGACGGGCGCGCGGTCTACTTCTACTCGGACCCCGACCGCCTCCAGGCCCACCTCACCGGGATCTCGCCCGCCGACGCCCGCCACATCAAGGGCTTCTGCGACAACCTCCGCTCCTTCCGCAAGGCACTCGCCGTCTACCCCTTCCTCAAGCCGGTCGGGCTCATGGGCCGGGTCGAGCGGATGCGGATGCTCGCCGGGTTCCTGCCGTACTTCAACGCGGTCCGCAAGACGATCTCGGTCCTCATGCGGGACTACTCGGAGAAGTTCCAGAGCCCCCTGCTGCGGCGGGCGTTCAACTACGTCCTCTACGAGCGCCACCCCAACTTCCCCGTCCTGCCGACCCACTTCCAGATGGCCTCGCACGCCAACCTCTCCGCGGGCGTCCCCGAGGGCGGCTCGCTGGGCCTCGCGCGCTCCATCGAGGAGCGGTACGTGCGGCTCGGCGGCGAGGTCTCGTACAACACGAAGGTCGAAGAGGTCCTGATCGAGGGGGACACGGCGGTCGGGGTGCGGCTGAGCGACGGCACCGAGCTGCGCGCGGACATCGTCGTCGCCGCGTGCGACGGGCCCACGACGATGCGCTCGCTGCTCAAGGGCCGCGACCTCGGCAAGGAGTACGAGCGCCTCTACACCGACACGATCGAGAAGCCCGGCATGGTCTTCCCCGGGTACGTGACGCTCTTCCTCGGCCTGAAACGGGAGTTCCCCGAGGCCGACCCCTGCACGACGTACCTGCTCGACGACGCCACCGCCGAGCGGCTCACCGGCATCCGGCACTCCAGCATCAACGTCCAGTTCCGCAACCGGCACTACCCCGAGCTGTCCCCGCCGGGCACGAGCGTCGTCTACGCCACGTACTTCTGCGACATCGCGCCCTGGCGCGCGCTCGACGACGGCCCCGAGCAGCGCACGCGCCGCAGGGGCGGCGAGGAACTGCACACGCTCCCCGTCAAGCACGGGCGCGGCTACTACGCGGCCAAGCACCAAGTGCGCGACACACTCGTGGAGTTCCTGGAGGAGCGCTTCCCGGGGCTGAGCGAGTCCATCGCCGTGCGGGACGTGTCGACGCCGCTCACACAGGTCCGCTACACGGGCAACTTCGACGGCACCGTGCTCGGCTGGCAGCCCTTCGTGGAGAGCGGCGAGACGCTGGAGGAGCTGATCAAGAAGTACGGCCCCGGTGTCCCCGGACTCGGGAACTTCTACCAGTCGGGGGTCTGGGCCACGACCGGCGGGCTCATCCGCGCGGCGGCGGCCGGGCGGCACGTCATGCAGTTCGTGTGCCGCGACGACGGCAAGGAGTTCACGGCCTCCGTGGACACGCACGGCCCGCTGCCGACGCACCGGGTCATCCCGGTGGGGCCGAGGGTGCCGGGGCCGGCGGCGCAGGCCGCGGGCGGCGGAGTCGCGTCCTTACCCGTACCGCCCAAGCTCGTCCCGCAGAAGGAGGAATCCCGGTGA	MTSRSTAPPAQLAEEERQSARAGKRRETVLIIGAGLGGLSTGVYAQLNGYRSRVLEMHEIPGGCCTAWERGDYTLDACVSWLLGSGPGNEMHQIWLELGALQGKEVRHFDVFNVVRDTDGRAVYFYSDPDRLQAHLTGISPADARHIKGFCDNLRSFRKALAVYPFLKPVGLMGRVERMRMLAGFLPYFNAVRKTISVLMRDYSEKFQSPLLRRAFNYVLYERHPNFPVLPTHFQMASHANLSAGVPEGGSLGLARSIEERYVRLGGEVSYNTKVEEVLIEGDTAVGVRLSDGTELRADIVVAACDGPTTMRSLLKGRDLGKEYERLYTDTIEKPGMVFPGYVTLFLGLKREFPEADPCTTYLLDDATAERLTGIRHSSINVQFRNRHYPELSPPGTSVVYATYFCDIAPWRALDDGPEQRTRRRGGEELHTLPVKHGRGYYAAKHQVRDTLVEFLEERFPGLSESIAVRDVSTPLTQVRYTGNFDGTVLGWQPFVESGETLEELIKKYGPGVPGLGNFYQSGVWATTGGLIRAAAAGRHVMQFVCRDDGKEFTASVDTHGPLPTHRVIPVGPRVPGPAAQAAGGGVASLPVPPKLVPQKEESR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	127.70	gnl|BL_ORD_ID|4834|hsp_num:0	5821			306	522	rifampin
BGC0000996.1|Frontalamides_7 # 14253 # 15308 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.718	BGC0000996.1|Frontalamides_7 	14253	15308	+	Loose	660	48.9062	MexS	31.96	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGATCAGCAAGTGGGTCGTCCGCGAGCACGTCAAGGGCACCCCGGACGTCTCCCGCGTCTACGAGCGCGTGGACGAGGACATCGCCGTCGACCTCGCGCCGCACCAGATGCTCCTGCGCACGCGGTACGTCTCGGTCGACCCGTATCTCCAGGGCATCACGCTCGACACCCCGATCGGCGCGCACATGGGCGCCGACACGATCATGGAAGTGCTCGAAGCCGGGCCCGAAGCCCCCTTCCGCGAGGGTGAGCTGGTGCAGGGGTACGGGGGCTGGCGCTCGCACCTCGTGAGCGACGGGAAGCCCGAGCTGTGGGCGACGGGGACCTTCCCGATGGTCTTCCCCGCCTACCGGCGGCTGCGGCCCGAGTGGTACGACGACGGACTGCCGCTCTCGACGGCGCTCGGCGCGATGGGCGGGCCCGGGATGACCGCGTGGGGCACGCTCGGCAAGTTCCTCGACGTGCGCCCCGGCCAGACCCTCGTCATCAGCGGCGCCTCCGGCGCGGTCGGCGCCCTCGCCGGGCAGCTCGCGCGCCGCGCGGGCGCCCGCGTCGTCGGCACGACGTCGAGCCCCGTGAAACGCGACTACCTGCGCGGACTCGGCTTCGACGAGGTCATCCTCTACCGCCACGGCGACAGCCCCGAGTCGATCCGCGCCGCCCTGGAGGCCGCGGCCCCGGACGGCGTCGACCGCTACTTCGACAACCTCGGCGGCGCCGTCACGGACGCCGTCTTCTCGATGCTCACCGTGGACAGCCGCGTCGCGGTGTGCTGGCAGTGGGCCACGCAGGTGGGCGGCGAGGCGGTCGGGCCCCGCCTCTTCCCGTACATCATGTTCCCCCGCACCACGATCCGCGGGATCTTCTCCATCGAGTGGTTCACCGACGCCAACTGGCAGGCGCTGCACGAGGAACTGGGCGGCAGCATCCGGCGCGCCGAGGTCGTCAGCGACCAGACGGTGTACGAGGGCTTCGACGCGATCCCCCAGGCGTACCAGAGCCTCTACGGCGCGCGCGAGGCGAACCGGGGGAAGGTGCTGGTGGAGTTGTGA	VKISKWVVREHVKGTPDVSRVYERVDEDIAVDLAPHQMLLRTRYVSVDPYLQGITLDTPIGAHMGADTIMEVLEAGPEAPFREGELVQGYGGWRSHLVSDGKPELWATGTFPMVFPAYRRLRPEWYDDGLPLSTALGAMGGPGMTAWGTLGKFLDVRPGQTLVISGASGAVGALAGQLARRAGARVVGTTSSPVKRDYLRGLGFDEVILYRHGDSPESIRAALEAAAPDGVDRYFDNLGGAVTDAVFSMLTVDSRVAVCWQWATQVGGEAVGPRLFPYIMFPRTTIRGIFSIEWFTDANWQALHEELGGSIRRAEVVSDQTVYEGFDAIPQAYQSLYGAREANRGKVLVEL	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	103.54	gnl|BL_ORD_ID|1039|hsp_num:0	1041			390	672	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000996.1|Frontalamides_8 # 15394 # 16575 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.746	BGC0000996.1|Frontalamides_8 	15394	16575	+	Loose	400	26.5646	kamB	44.44	3004102	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (A1408)	GTGACCAGTACCCTCCCCGCCCCCCTGCCCCCGCTGCACCGCATCCCCAGCGCACCCTGCGCGGCTCCGCACCCGGTCGTCCTGCCCGACGGGGCGGCGGCGTGGCGCGTGAGCAGATACGCGGACGTCCGCGAAGTCCTCGGCGGAGGGGGCTTCACCCGGGCCGCGCTCTACGCCGAGGAGCACGACGACCGGCCGAGCGGCGGCGGCATCGTCGACGACCCCGAACTCCTCTTCAACCAGGACGGCCCCGAGCACCTGCGGCTGCGCCGCACGGTCGGCCGCGCCTTCACGCCGCGCGCGGTGGCCCGCTGGGAACCGTGGATCACCGCGACGGTCGAGGAACTGCTCGACGGGCTCGTCCGGCACGAGGGCCCCTTCGACCTCGTCTCCGGACTCGCCCGGCCGCTCCCCGTCACCGTCATCACCCGGCTCCTGGGCCTCGAAGGGGACGCGTGGGAGAAGATCGGCTACTGGAGCGACCTGGCCTTCACGGACGGCTCGCACTCGGCGGCCGAAGTCGAGTCCGGACTGGCTGACTTCACGAGCTTCGGCGGCGAACTCCTCGCCCTGCGCCGCAAGGAGCCCGGCGACGACCTCGTGAGCGGCATCGTGCGCGCCGCCGACGCCGAGGGCGGCATCCCCGAGTCCCAACTCGTCCGCCTCGTCTGCGGAATGGTCGTGGGCGGGCACGACAGCACCATGACGATGCTCGGCAACGTGCTCCTCTACCTCCTCGGCGAACGCCGCGACGCCTGGCCGCGCCTCACCGACGTCGACGCGGCGGGACTCGCCGCCGACCGGCTCCTCCACCTCGTGCCCCTCGGCGAGGACCCCGGCAGCCTGCGCCGCTGCGTCGCCGACACCGACCTCGGCGGTGTCCGCGTCCCGGCGGGCGCGATCGTCGTGGCCGACATCGTCGCGGCCAACCGAGACCCCGAGGTCTTCCCGCCCGCCGAGACCGACGACCTCTTCCGCGAACTCCCCGCCCCCACGCTCGCCTTCGGCGGCGGCCCGCACTACTGCATGGGCGCCTGGCTCGCCCGCCTCGAACTCCGCACCGCCCTGAACCGCCTCGCGACCCGCCTCCCCGAGCTGCGACTCGTCCCGGGCGACGGGGGAGTGGAGTGGCGGCTCGGCACGACCTCGCGGGGGCCGAAGCGGCTGATGGCGGTGGGGTGA	MTSTLPAPLPPLHRIPSAPCAAPHPVVLPDGAAAWRVSRYADVREVLGGGGFTRAALYAEEHDDRPSGGGIVDDPELLFNQDGPEHLRLRRTVGRAFTPRAVARWEPWITATVEELLDGLVRHEGPFDLVSGLARPLPVTVITRLLGLEGDAWEKIGYWSDLAFTDGSHSAAEVESGLADFTSFGGELLALRRKEPGDDLVSGIVRAADAEGGIPESQLVRLVCGMVVGGHDSTMTMLGNVLLYLLGERRDAWPRLTDVDAAGLAADRLLHLVPLGEDPGSLRRCVADTDLGGVRVPAGAIVVADIVAANRDPEVFPPAETDDLFRELPAPTLAFGGGPHYCMGAWLARLELRTALNRLATRLPELRLVPGDGGVEWRLGTTSRGPKRLMAVG	MRRVVGKRVQEFSDAEFEQLRSQYDDVVLDVGTGDGKHPYKVARQNPSRLVVALDADKSRMEKISAKAAAKPAKGGLPNLLYLWATAERLPPLSGVGELHVLMPWGSLLRGVLGSSPEMLRGMAAVCRPGASFLVALNLHAWRPSVPEVGEHPEPTPDSADEWLAPRYAEAGWKLADCRYLEPEEVAGLETSWTRRLHSSRDRFDVLALTGTISP	182.79	gnl|BL_ORD_ID|2390|hsp_num:0	2770			429	510	neomycin; apramycin; kanamycin A
